Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia

Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia

Acute myeloid leukemia (AML) is a malignant clonal tumor originating from immature myeloid hematopoietic cells in the bone marrow with rapid progression and poor prognosis. Therefore, an in-depth exploration of the pathogenesis of AML can provide new ideas for the treatment of AML. In recent years,...

Full description

Bibliographic Details
Main Authors: Wandi Wang, Xiaofang Wu, Jiamian Zheng, Ran Yin, Yangqiu Li, Xiuli Wu, Ling Xu, Zhenyi Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
acute myeloid leukemia
exosomes
prognosis
biomarker
immune evasion
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1315453/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1315453/full

Similar Items